|
|||||
|
Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter |
Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
NEUE | Manders Matthew G | Director | May 13 | Option Exercise | 0.00 | 118,886 | 0 | 118,886 | May 16 08:20 PM |
CI | Manders Matthew G | Pres, Government and Solutions | Mar 01 | Sale | 212.37 | 3,087 | 655,586 | 44,569 | Mar 02 08:27 PM |
CI | Manders Matthew G | Pres, Government and Solutions | Jan 21 | Sale | 230.06 | 5,596 | 1,287,438 | 40,422 | Jan 25 06:40 PM |
CI | Manders Matthew G | President, Strategy & Solution | Mar 02 | Sale | 182.85 | 3,969 | 725,732 | 46,018 | Mar 02 08:46 PM |
CI | Manders Matthew G | Pres. Gov't & Ind Prog & Group | Jul 20 | Option Exercise | 44.42 | 12,457 | 553,402 | 46,256 | Jul 24 05:36 PM |
CI | Manders Matthew G | Pres. Gov't & Ind Prog & Group | Jul 21 | Option Exercise | 44.42 | 11,900 | 528,658 | 45,699 | Jul 24 05:36 PM |
CI | Manders Matthew G | Pres. Gov't & Ind Prog & Group | Jul 24 | Option Exercise | 44.42 | 5,596 | 248,602 | 39,395 | Jul 24 05:36 PM |
CI | Manders Matthew G | Pres. Gov't & Ind Prog & Group | Jul 21 | Sale | 175.01 | 11,900 | 2,082,665 | 33,799 | Jul 24 05:36 PM |
CI | Manders Matthew G | Pres. Gov't & Ind Prog & Group | Jul 20 | Sale | 175.01 | 12,457 | 2,180,062 | 33,799 | Jul 24 05:36 PM |
CI | Manders Matthew G | Pres. Gov't & Ind Prog & Group | Jun 02 | Sale | 165.00 | 6,000 | 990,000 | 33,799 | Jun 06 05:44 PM |
CI | Manders Matthew G | Pres. Gov't & Ind Prog & Group | Feb 27 | Sale | 146.54 | 8,309 | 1,217,601 | 39,799 | Mar 01 05:54 PM |
CI | Manders Matthew G | Pres. US Comm Mkts & Gbl HC Op | Mar 04 | Sale | 138.68 | 14,586 | 2,022,737 | 47,799 | Mar 08 05:56 PM |
CI | Manders Matthew G | Pres. US Comm Mkts & Gbl HC Op | May 13 | Sale | 132.43 | 3,028 | 400,998 | 47,799 | May 15 05:33 PM |
CI | Manders Matthew G | Pres. US Comm Mkts & Gbl HC Op | Mar 06 | Sale | 120.95 | 15,263 | 1,846,087 | 50,827 | Mar 10 05:52 PM |
CI | Manders Matthew G | Pres. US Comm Mkts & Gbl HC Op | Feb 13 | Option Exercise | 42.19 | 20,167 | 850,846 | 67,175 | Feb 18 07:13 PM |
CI | Manders Matthew G | Pres. US Comm Mkts & Gbl HC Op | Feb 17 | Option Exercise | 42.19 | 3,819 | 161,124 | 50,827 | Feb 18 07:13 PM |
CI | Manders Matthew G | Pres. US Comm Mkts & Gbl HC Op | Feb 13 | Sale | 114.10 | 20,167 | 2,301,041 | 47,008 | Feb 18 07:13 PM |
CI | Manders Matthew G | Pres. US Comm Mkts & Gbl HC Op | Aug 14 | Option Exercise | 47.92 | 13,646 | 653,985 | 65,382 | Aug 18 06:07 PM |
CI | Manders Matthew G | Pres. US Comm Mkts & Gbl HC Op | Aug 14 | Sale | 91.63 | 18,374 | 1,683,612 | 47,008 | Aug 18 06:07 PM |
CI | Manders Matthew G | Pres. Regional & Operations | May 12 | Option Exercise | 46.88 | 12,933 | 606,342 | 61,641 | May 14 05:10 PM |
CI | Manders Matthew G | Pres. Regional & Operations | May 12 | Sale | 87.79 | 9,905 | 869,538 | 51,736 | May 14 05:10 PM |
CI | Manders Matthew G | Pres. Regional & Operations | Mar 07 | Sale | 79.34 | 18,136 | 1,438,874 | 48,708 | Mar 11 06:35 PM |
CI | Manders Matthew G | Pres. Regional & Operations | Jun 10 | Option Exercise | 31.16 | 50,772 | 1,582,074 | 101,522 | Jun 12 06:53 PM |
CI | Manders Matthew G | Pres. Regional & Operations | Jun 10 | Sale | 68.74 | 36,821 | 2,531,238 | 64,701 | Jun 12 06:53 PM |
CI | Manders Matthew G | Pres. Regional & Operations | Jun 12 | Sale | 69.62 | 47 | 3,272 | 64,654 | Jun 12 06:53 PM |
CI | Manders Matthew G | Pres. Regional & Operations | Mar 05 | Sale | 58.76 | 14,733 | 865,649 | 50,750 | Mar 07 09:52 PM |
CI | Manders Matthew G | Pres. US Svc, Clinical & Spec | May 09 | Option Exercise | 14.03 | 13,132 | 184,176 | 59,422 | May 11 07:38 PM |
CI | Manders Matthew G | Pres. US Svc, Clinical & Spec | May 09 | Sale | 47.22 | 7,873 | 371,750 | 51,549 | May 11 07:38 PM |
CI | Manders Matthew G | Pres. US Svc, Clinical & Spec | Dec 14 | Option Exercise | 18.65 | 18,591 | 346,812 | 59,610 | Dec 16 07:18 PM |
CI | Manders Matthew G | Pres. US Svc, Clinical & Spec | Dec 14 | Sale | 37.21 | 13,320 | 495,589 | 46,290 | Dec 16 07:18 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite